Introduction: The COVID-19 pandemic has challenged societies, not only because of its magnitude and impact, but also because it has deepened health inequalities and inequities. Socially disadvantaged groups show a higher frequency of adverse health events due to COVID-19, particularly in Latin America. With that in mind, we describe the distribution of deaths in COVID-19 patients stratified by sociodemographic characteristics and medical comorbidities, and explore perceptions related to disease-care, in selected rural and urban localities from Sonora, Mexico. Methods: We conducted a cross-sectional study on 160 deaths attributed to COVID-19, from the period April 1st and July 31st 2020, using death certificates as a data source. Furthermore, to explore the variables of interest, a verbal autopsy was applied to a relative caregiver for the patient’s health. Data collected was analyzed by descriptive statistics and qualitative technique. Results: We did not find significant differences in sociodemographic conditions among the COVID-19 deaths. Interestingly, 85.6% of the deceased had a chronic medical condition and 74.4% of all deaths took place in an urban locality. Caregivers frequently consigned deficiencies from medical services over the disease-care process of COVID-19 deaths.
Background: Estimating years of potential life lost (YPLL) emphasizes causes of death that disproportionally affect younger populations, contributing to a more comprehensive understanding of the burden of the COVID-19 pandemic. This study estimated the YPLL due to COVID-19 in the state of Sonora, Mexico, from 2020 to 2022. Methods: We conducted an observational, cross-sectional study using mortality data from 2020 to 2022. YPLL was estimated following the methodology of the Global Burden of Disease (GBD) Study. Results were stratified by selected sociodemographic characteristics. Results: A total of 12,021 COVID-19 deaths were recorded in Sonora, resulting in 171 173.25 YPLL. Men experienced higher YPLL than women across most age groups. Adults aged 55–69 accounted for 39.0% of total YPLL. Among individuals aged ≤40 years, YPLL rose from 6,889 in 2020 (7.7%) to 7,742 in 2021 (11.5%). Higher average YPLL was observed among individuals with partners (15.10), without entitlement to health services (15.3), with high school education (17.69) and those residing in urban areas (14.33). Conclussion: These findings underscore the value of YPLL estimation in capturing premature mortality that traditional death counts may overlook. This approach offers a more nuanced understanding of the pandemic’s impact and supports the need for more equitable and targeted public health interventions, particularly in regional contexts such as northwestern Mexico.
Background/Objectives: Excess mortality (EM) is a key indicator for assessing the population-level impact of large-scale health crises, particularly when cause-of-death ascertainment is incomplete or delayed. However, EM estimates are sensitive to methodological decisions, highlighting the need for operationally feasible approaches suitable for routine public health surveillance. Methods: We conducted time series analyses of routinely collected mortality data from a subnational setting in northern Mexico. Deaths recorded between 2015 and 2022 were grouped into 28 cause-of-death categories. Expected deaths during the COVID-19 pandemic period (March 2020–July 2022) were estimated using negative binomial regression models fitted to pre-pandemic data (2015–2019), incorporating a linear trend and monthly indicators to account for long-term trends and seasonality. Newey–West standard errors were used to address serial correlation and heteroskedasticity. EM was defined as the difference between observed and expected deaths. Results: An estimated 14,482 excess deaths were observed during the pandemic period, corresponding to a 30.9% increase relative to expected mortality. Time-series models identified four distinct peaks of excess mortality coinciding with major pandemic waves. Although COVID-19 accounted for most excess deaths, among non-COVID causes, only ischemic heart disease and diabetes showed statistically significant excess mortality among major non-communicable diseases after baseline adjustment. However, additional categories—including non-transport-related accidents, ill-defined causes, and other endocrine, metabolic, hematological, and immunological diseases—also exhibited statistically significant excess mortality. For several causes, increases in crude mortality did not translate into statistically significant excess mortality. Conclusions: Negative binomial time series regression provides an implementable framework for estimating EM, underscoring the importance of expected mortality estimation for understanding population-level mortality dynamics during health emergencies.